Endocrine and metabolic disorders associated with human immune deficiency virus infection

West African Journal of Medicine

Volumn 28, Issue 1, 2009, Pages 3-9

  Unachukwu, C N ^a   Uchenna, D I ^a   Young, E E ^a  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Endocrinopathies; HIV; Metabolic disorders; Review

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMPRENAVIR; ANDROGEN; CONJUGATED ESTROGEN; FLUTICASONE; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDINAVIR; KETOCONAZOLE; LEVOTHYROXINE; MEGESTROL ACETATE; METFORMIN; OXANDROLONE; PENTAMIDINE; PROGESTERONE; PROTEINASE INHIBITOR; RIFAMPICIN; RITONAVIR; STAVUDINE; TESTOSTERONE; TRIMETHOPRIM; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADENOHYPOPHYSIS; ADRENAL DISEASE; ADRENAL INSUFFICIENCY; AMENORRHEA; AWARENESS; CANCER INFILTRATION; CHOLESTEROL BLOOD LEVEL; CUSHING SYNDROME; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; EARLY INTERVENTION; ENDOCRINE DISEASE; EUTHYROID SICK SYNDROME; GALACTORRHEA; GLUCOSE METABOLISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPONATREMIA; HYPOPHYSIS DISEASE; HYPOTHYROIDISM; INSULIN RESISTANCE; LIPODYSTROPHY; METABOLIC DISORDER; METABOLIC SYNDROME X; NEUROHYPOPHYSIS; OPPORTUNISTIC INFECTION; PANCREAS DISEASE; PATHOGENESIS; REVIEW; SIDE EFFECT; TARGET ORGAN; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL; THYROID DISEASE; TRIACYLGLYCEROL BLOOD LEVEL; COMPLICATION; ENDOCRINE SYSTEM DISEASES; HIV INFECTIONS; METABOLIC DISEASES; NIGERIA; RISK FACTOR;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ENDOCRINE SYSTEM DISEASES; HIV INFECTIONS; HUMANS; METABOLIC DISEASES; NIGERIA; RISK FACTORS;

EID: 67650497261     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: 10.4314/wajm.v28i1.48415     Document Type: Review

References (50)

1. Finch RA, Moss P, Jeffries DJ, Anderson J. Infectious diseases, tropical medicine and sexually transmitted diseases. In: Kumar P, Clark M, eds. Clinical Medicine, London, Elsevier Saunders; 2005: 19-152.
2. Smith D. Endocrine complications in HIV progression. AIDS Treatment News, 1991: # 140.
3. Schwartz Lj, St Louis Y, Wu R, Wiznia A, Rubinstein A, Saenger P. Endocrine function in children with HIV infection. Am J Dis Child 1991; 145: 330-333.
4. Croxson TS, Chapman WE, Miller LK. Serum Prolactin concentrations in patients with the acquired immunodeficiency syndrome. Crit Care Med 1990; 18: 440-441. (Pubitemid 20138328)
5. Hutchinson J, Murphy M, Harries R, Skinner CJ. Galactorrhoea and hyperprolactinaemia associated with protease inhibitors. Lancet 2000; 356: 1003-1004.
6. Milligan SA, Katz MS, Craven PC. Toxoplasmosis presenting as panhypopituitarism in a patient with the acquired immunodeficiency syndrome. Am J Med 1984; 77: 760-764. (Pubitemid 14047616)
7. Coodley GO, Loveless MO, Nelson HD, Endocrine functionin the HIV Wasting Syndrome. J AIDS 1994; 7: 46-51. (Pubitemid 2023018)
8. Sano T, Kovacs K, Scheithauer BW. Pituitary pathology in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1989; 113: 1066-1070. (Pubitemid 19228105)
9. Vitting KE, Gardenswartz MH, Zabetakis PM, Frequency of hyponatraemia and nonosolar vasopressin release in the acquired immunodeficiency syndrome. JAMA 1990; 263: 973-978. (Pubitemid 20061543)
10. Cusano AJ, Thies HL, Siegal FP, Hyponatraemia in patients with acquired immunodeficiency syndrome. J Acquir Imune Defic Syndr Hum Retrvirol 1990; 3: 949-953. (Pubitemid 20330686)
11. Agarwal A, Soni A, Ciechanowsky M, Chander P, Treser G. Hyponatraemia in patients with the acquired immunodeficiency syndrome. Nephron 1989; 53: 317-321. (Pubitemid 19267245)
12. Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, et al. Brief report: trimethoprim-induced hyperkalaemia in a patient with AIDS. N Engl J Med 1993; 328: 703-706. (Pubitemid 23073373)
13. Madhoun ZT, DuBois DB, Rosenthal J, Findlay JC, Aron DC. Central diabetes insipidus: a complication of herpes simplex Type2 encephalitis in a patient with AIDS. Am J Med. 1991; 90: 658-659.
14. Hoffman JC and Brown T. Thyroid Function Abnormalities in HIV infected patients Clin Infect Dis 2007; 45: 488-494.
15. Jameson JL, Weetman AP. Disorders of the thyroid gland. In: Jameson JL ed. Harrisons Endocrinology, New York, McGraw-Hill Companies; 2006: 71-110.
16. Beltran S, Lescure F-X, Desailloud R, Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clin Infect Dis 2003; 37: 579-583 (Pubitemid 37011783)
17. Madeddu G, Spanu A, Chessa F, Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy. Clin Endocrinol (Oxf) 2006; 64: 375-383
18. Beltran S, Lescure F-X, Esper IE, Schmit J-L, Desailloud R. Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease. Horm Res 2006; 66: 21-26. (Pubitemid 43952584)
19. Grappin M, Piroth L, Verges B, Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS 2000; 14: 1070-1072. (Pubitemid 30336075)
20. Knysz B et al. Graves' disease as an autoimmune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review. Viral Immunol. 2006 Spring; 19: 102-107.
21. Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 2006; 17: 518-32.
22. Ranieri R, Veronelli A, Santambrogio C, Colombo L, Pontiroli AE. Subclinical hypothyroidism in a patient affected by advanced AIDS and visceral leishmaniasis. Scand J Infect Dis 2005; 37: 935-937. (Pubitemid 43078111)
23. Johnson SR. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr. 2006; 148: 386-388.
24. Bricaire F, Marche C, Zoubi D, Adrenal lesions in AIDS: anatomopathological study. Ann Med Interne 1987; 138: 607-609. (Pubitemid 18071872)
25. Klatt EC, Shibata D. Cytomegalovirus infection in the acquired immunodeficiency syndrome: Clinical and autopsy findings. Arch Pathol Lab Med 1988; 112: 540-544. (Pubitemid 18117273)
26. Membreno L, Irony I, Dere W. Adrenocortical function in acquired immuno deficiency syndrome. J Clin Endocrinol Metab 1987; 65: 482-487. (Pubitemid 17131436)
27. Kalin MF, Poretsky L, Seres DS. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med 1987; 82: 1035-1038. (Pubitemid 18131353)
28. Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med 1989; 87: 260-263. (Pubitemid 19234276)
29. Villette JM, Bourin P, Doinel C, Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 1990; 70: 572-577. (Pubitemid 20092426)
30. Croxson TS, Chapman WE, Miller LK, Changes in the hypothalamic-pituitary- gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab 1989; 68: 317-321. (Pubitemid 19052870)
31. Dobs AS, Dempsey MA, Ladenson PW, Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988; 84: 611-616.
32. Cohan GR HIV-associated hypogonadism AIDS Read. 2006; 16: 341-345, 352-354.
33. Wunder D M Bessinger NA Fux C Mueller NJ Hirschel B Cavassini M et al. Swiss HIV Cohort Study. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir Ther. 2007; 12: 261-265
34. Crum-Ciaflone NM Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007; 21: 9-19. (Pubitemid 46214159)
35. Cejtin H E Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction. Obstet Gynecol. 2006; 108: 1423-1431 (Pubitemid 44901017)
36. Dowell SF, Moore GW, Hutchins GM. The spectrum of pancreatic pathology in patients with AIDS. Mod Pathol 1996; 3: 49-53.
37. Hommes MJT, Romihn JA, Endert E, Schattenkerk JKME, Sauerwein HP. Insulin sensitivity and insulin clearance in human immunodeficiencv virus-infected men. Metabolism 1991; 40: 651-656.
38. Osei K, Falko JM, Nelson KP, Stephens R. Diabetogenic effect of pentamidine: in vitro and in vivo studies in a patient with malignant insulinoma. Am J Med 1984; 77: 41-46. (Pubitemid 14084904)
39. Murata H, Hiruz PW, Mueckler M. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem 2000; 275: 20251-20254. (Pubitemid 30457596)
40. Caron M, Auelair M, Vigoureux C. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation and induces insulin resistance. Diabetes 2001; 50: 1378-1388. (Pubitemid 32500171)
41. Carr AK, Samaras, Burton SA. Syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-8.
42. Bakari AG, Sani-Bello F, Shehu MS, Mai A, Aliyu IS, Lawal II. Anti-retroviral therapy induced diabetes in a Nigerian. African Health Sciences 2007; 7: 134-136.
43. Hadigan C, Corcoran C, Basgoz N, Davis B, Sax P, Grinspoon S. Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial. JAMA 2000; 284: 472-477. (Pubitemid 30484481)
44. Hadigan C, Meigs JB, Rab J. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J. Clin Endocrinol Metab 2001; 86: 939-943. (Pubitemid 32207521)
45. Driscoll SD, Meininger GE, Lareau MT. Effects of exercise training and metformin on body composition and cardiovascular indices in HIV infected patients. AIDS 2004; 18: 465-473. (Pubitemid 38365874)
46. Grunfeld C, Kotler DP, Shigenaga JK, Doenler W, Tierney A, Wang J et al. Circulating interferon á levels and hypertriglyceridaemia in the acquired immune deficiency syndrome. Am J Med 1991; 90: 154-162.
47. Danner SA, Carr A, Lenard JM. A short-term study of the safety, pharmacokinetics and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Study Group. N Engl J Med 1995; 333: 1528-1533.
48. Lo J C, Mulligan K, Tai V W, Algren H, Schambelan M. Body shape changes in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 307-308 (Pubitemid 28489755)
49. Jain RG, Furtine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with anti-retroviral therapy. Antiviral Res 2001; 51: 151-177. (Pubitemid 32622833)
50. Kino T, Mirani M, Alesci S, Chrousos GP. AIDS-related lipodystrophy / insulin resistance syndrome. Horm Metab Res 2003; 35: 129-136. (Pubitemid 36577852)